Amgen's master builder remembers what it was like to build the first start-up pharmaceutical company since Syntex
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rathmann, G. Knocking on Opportunity's Window. Nat Biotechnol 11, S27–S32 (1993). https://doi.org/10.1038/nbt0393-S27
Issue Date:
DOI: https://doi.org/10.1038/nbt0393-S27